Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 817

1.

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.

Mueller JE, Borrow R, Gessner BD.

Expert Rev Vaccines. 2006 Jun;5(3):319-36. Review.

PMID:
16827617
2.

[Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].

du Châtelet IP, Alonso JM, Taha MK.

Bull Soc Pathol Exot. 2002 Dec;95(5):323-4; discussion 324-5. Review. French.

PMID:
12696368
3.

The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.

Traoré Y, Njanpop-Lafourcade BM, Adjogble KL, Lourd M, Yaro S, Nacro B, Drabo A, Parent du Châtelet I, Mueller JE, Taha MK, Borrow R, Nicolas P, Alonso JM, Gessner BD.

Clin Infect Dis. 2006 Oct 1;43(7):817-22. Epub 2006 Aug 22.

PMID:
16941360
4.

Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso.

Decosas J, Koama JB.

Lancet Infect Dis. 2002 Dec;2(12):763-5.

PMID:
12467693
5.

Increase in Neisseria meningitidis serogroup W135, Niger, 2010.

Collard JM, Maman Z, Yacouba H, Djibo S, Nicolas P, Jusot JF, Rocourt J, Maitournam R.

Emerg Infect Dis. 2010 Sep;16(9):1496-8. doi: 10.3201/eid1609.100510. No abstract available.

6.

New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.

Chanteau S, Dartevelle S, Mahamane AE, Djibo S, Boisier P, Nato F.

PLoS Med. 2006 Sep;3(9):e337.

7.

Control of meningococcal meningitis outbreaks in sub-Saharan Africa.

Chippaux JP.

J Infect Dev Ctries. 2008 Oct 1;2(5):335-45. Review.

8.

[From genomics to surveillance, prevention and control: new challenges for the African meningitis belt].

Alonso JM, Bertherat E, Perea W, Borrow R, Chanteau S, Cohet C, Dodet B, Greenwood B, LaForce FM, Muros-Le Rouzic E, Teyssou R, Ouédraogo-Traoré R, Sow I.

Bull Soc Pathol Exot. 2006 Dec;99(5):404-8. French.

PMID:
17253061
9.

Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa.

von Gottberg A, du Plessis M, Cohen C, Prentice E, Schrag S, de Gouveia L, Coulson G, de Jong G, Klugman K; Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa.

Clin Infect Dis. 2008 Feb 1;46(3):377-86. doi: 10.1086/525260.

PMID:
18181736
10.

Emergence of W135 meningococcal meningitis in Ghana.

Forgor AA, Leimkugel J, Hodgson A, Bugri A, Dangy JP, Gagneux S, Smith T, Pluschke G.

Trop Med Int Health. 2005 Dec;10(12):1229-34.

11.

Meningitis epidemics in Africa: a brief overview.

Teyssou R, Muros-Le Rouzic E.

Vaccine. 2007 Sep 3;25 Suppl 1:A3-7. Epub 2007 May 15. Review.

PMID:
17643560
12.

Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Nelson CB, Birmingham M, Costa A, Daviaud J, Perea W, Kieny MP, Tarantola D.

Am J Public Health. 2007 Apr;97 Suppl 1:S15-22. Epub 2007 Apr 5.

13.

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.

Xie O, Pollard AJ, Mueller JE, Norheim G.

Vaccine. 2013 Jun 12;31(27):2852-61. doi: 10.1016/j.vaccine.2013.04.036. Epub 2013 Apr 24. Review.

PMID:
23623866
14.

Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.

Boisier P, Djibo S, Sidikou F, Mindadou H, Kairo KK, Djibo A, Goumbi K, Chanteau S.

Trop Med Int Health. 2005 May;10(5):435-43.

15.

Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.

Robbins JB, Schneerson R, Gotschlich EC, Mohammed I, Nasidi A, Chippaux JP, Bernardino L, Maiga MA.

Bull World Health Organ. 2003;81(10):745-50; discussion 751-5. Epub 2003 Nov 25.

16.

Meningococcal vaccine in travelers.

Wilder-Smith A.

Curr Opin Infect Dis. 2007 Oct;20(5):454-60. Review.

PMID:
17762777
17.

The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: main lessons learnt.

Zombré S, Hacen MM, Ouango G, Sanou S, Adamou Y, Koumaré B, Kondé MK.

Vaccine. 2007 Sep 3;25 Suppl 1:A69-71. Epub 2007 May 7.

PMID:
17630052
18.

Meningococcal immunology.

Lepow ML, Hughes PA.

Immunol Allergy Clin North Am. 2003 Nov;23(4):769-86. Review.

PMID:
14753391
19.

Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.

Mueller JE, Yaro S, Traore Y, Sangare L, Tarnagda Z, Njanpop-Lafourcade BM, Borrow R, Gessner BD.

J Infect Dis. 2006 Mar 15;193(6):812-20. Epub 2006 Feb 8.

PMID:
16479516
20.

[Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].

Chippaux JP, Debois H, Saliou P.

Bull Soc Pathol Exot. 2002 Mar;95(1):37-44. Review. French.

PMID:
12012963

Supplemental Content

Support Center